FDA Steps Up Campaign Against Rx Imports; Bill “Technically” Flawed
Executive Summary
Pending federal legislation to allow importation of prescription drugs from Canada would create unworkable conflicts with state pharmacy laws, FDA Commissioner Mark McClellan told the National Association of Boards of Pharmacy legislative conference Sept. 14 in Washington, D.C
You may also be interested in...
Illinois Reimportation Plan Goes Beyond Canada, Enlists PBM
Illinois will contract with a non-domestic PBM to administer personal drug reimportation from Ireland, the United Kingdom and Canada
Illinois Reimportation Plan Goes Beyond Canada, Enlists PBM
Illinois will contract with a non-domestic PBM to administer personal drug reimportation from Ireland, the United Kingdom and Canada
FDA warns drug importers
FDA issues Jan. 22 warning letter to Temple, Texas-based Expedite Rx and affiliated companies SPC Global Technologies and Employer Health Options for selling prescription drugs imported from Canada. In the letter, FDA says Expedite Rx' web site is "misleading" for stating that FDA has taken a "compassionate approach" to enforcement. FDA has said it is stepping up investigations of imported drugs, and has made several well-publicized seizures of drug repackagers (1"The Pink Sheet" Sept. 22, 2003, p. 3)...
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: